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Open access under the ElDespite the fact that TRPV1 receptors are widely expressed in brain structures such as the hippocampus,
its functions remain largely unknown. In the present study, we have investigated the possible modulatory
role of the hippocampal endovanilloid system upon memory consolidation of two different behavioral
tasks in rats. Post-training infusion of the TRPV1 antagonist capsazepine disrupted memory consolidation
with a strong training protocol, but not with a weak one in the contextual fear conditioning or in the step-
down inhibitory avoidance task. These results provide evidence that the modulation of the hippocampal
memory consolidation through TRPV1 receptors takes place only in presence of a strong emotional expe-
rience, suggesting that a certain aversiveness level is required in order to recruit endovanilloids to exert
this function. A possible synergic role of hippocampal endovanilloid and endocannabinoid system on
memory consolidation is discussed.
 2012 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
TRPV1 (transient receptor potential vanilloid type 1), originally
called VR1, is a calcium-permeable cation channel (Szallasi &
Blumberg, 1999). In the peripheral nervous system, this receptor
can be modulated by high temperatures, extracellular protons
and chemical ligands, such as capsaicin and the endocannabinoid
anandamide (Al-Hayani, Wease, Ross, Perwtee, & Davies, 2001;
Smart et al., 2000; Tominaga et al., 1998). Although TRPV1 chan-
nels are highly expressed in primary sensory afferent neurons, they
are also present in brain areas, including the hippocampus (Mezey
et al., 2000; Tóth et al., 2005). In this brain structure, TRPV1 recep-
tors are mainly found in the postsynaptic dendrites spines and cell
somata (Cristino et al., 2006; Tóth et al., 2005). In contrast, a recent
study has reported a restricted expression of TRPV1 receptors in
the brain (Cavanaugh et al., 2011). Nonetheless, electrophysiologi-
cal studies strongly support the expression and functional role of
the TRPV1 receptors in the brain, such as its involvement in long
term potentiation (LTP) (Bennion et al., 2011; Marsch et al.,
2007) and long term depression (LTD) (Chávez, Chiu, & Castillo,
2010) in the hippocampus.
Three classes of endovanilloids activate TRPV1 directly: ananda-
mide, N-acyldopamines (e.g., N-arachidonyl-dopamine or NADA)rk.
sevier OA license.and hydroperoxyeicosatetraenoic acids (HPETEs) (Huang et al.,
2002; Ross, 2003; Zygmunt et al., 1999). Both anandamide and
NADA are also members of the endocannabinoid family, since they
bind to CB1 receptors as well. In fact, TRPV1 and CB1 are colocal-
ized in several brain structures, including the hippocampus (Cristi-
no et al., 2006). However, whereas TRPV1 receptors are found in
the postsynaptic membrane (Tóth et al., 2005), CB1 receptors are
expressed mostly presynaptically in axon terminals (Wilson & Ni-
coll, 2002). Despite extensive work showing the involvement of
CB1 receptors in brain functions such as memory (Abush & Akirav,
2010; de Oliveira Alvares et al., 2005), TRPV1 roles in the CNS re-
main largely unknown. Recent report has shown an axiolytic effect
of TRPV1 antagonist infused into the medial prefrontal cortex, sug-
gesting that the TRPV1 receptors may participate on the modula-
tion of the anxiety behavior (Aguiar, Terzian, Guimarães, &
Moreira, 2009; see Moreira, Aguiar, Terzian, Guimarães, & Wotjak,
2011 for a wider review).
Two recent studies, either using TRPV1 knock-out mice or phar-
macological tools, have found some behavioral and synaptic
plasticity effects of endovanilloids acting upon TRPV1 receptors.
Marsch and colleagues have reported that TRPV1-deﬁcient mice
show less anxiety-like behavior in the elevated plus maze and
dark-light transition task than the wild-type littermate. They also
display a poor contextual fear memory with strong (but not with
moderate) training stimulus, and a weaker LTP induction (Marsch
et al., 2007). Li and collaborators have demonstrated that the
TRPV1 agonist capsaicin both facilitated LTP in hippocampal CA1
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acute stress, while the selective antagonist capsazepine was able
to suppress long-term depression (Li et al., 2008).
Interestingly, in both studies, the endovanilloid function on
memory appears to be important when some level of stress is pres-
ent. However, in the ﬁrst study it was not possible to conclude if
the memory effect acted upon acquisition or retrieval. Moreover,
since the TRPV1 receptors expression are constitutively arrested
in these genetically modiﬁed mice, a compensatory process and/
or differences in genetic background may have contributed to the
phenotype observed (Marsch et al., 2007).
In the present study we aim to perform a deeper evaluation of
the modulatory role of the dorsal hippocampus endovanilloid sys-
tem – using TRPV1 agonists or antagonists – on memory consolida-
tion. Drugs were infused immediately after training in two aversive
tasks with different stress/aversiveness levels.2. Material and methods
2.1. Animals
In the experiments, 248 male Wistar rats (age 3–4 months,
weight 270–320 g) from our breeding colony were used. The ani-
mals were housed in plastic home-cages, 4–5 per cage, under a
12-h light/dark cycle and at constant temperature (24 ± 1 C), with
water and food available ad libitum. Behavioral tests were per-
formed at daytime only.
2.2. Stereotaxic surgery and cannulae placement
Rats were deeply anesthetized by an i.p. injection of ketamine/
xylazine (75 and 10 mg/kg, respectively) and bilaterally implanted
with 27-gauge guide cannulae aimed at AP _4.2 mm (from
bregma), LL ±3.0 mm, DV 1.8 mm, positioned just 1.0 mm above
the region of the dorsal hippocampus (according to Paxinos and
Watson (1998)). Before the behavioral tests, animals were allowed
a recovery period of 5–7 days.
2.3. Drugs and administration
Capsaicin and capsazepine (Tocris) were dissolved in a vehicle
solution (8% DMSO in 0.1 M of a phosphate-buffered saline – PBS
solution). At the time of infusion, 30-gauge infusion cannulae
was ﬁtted into the guide cannulae, its tip protruding 1.0 mm from
the cannulae end, and aimed at the pyramidal cell layer of CA1 in
the dorsal hippocampus. A volume of 0.5 ll of capsaicin (0.1, 1 and
10 lM), capsazepine (2, 10 and 20 lM), or vehicle (control group)
was mechanically and slowly infused (during 90 s) immediately
after training.
2.4. Step-down inhibitory avoidance (IA)
The step-down inhibitory avoidance task was carried out in an
automatically operated, brightly illuminated box (Albarsch; 15 W
lamp), in which the left extreme of the grid (42.0  25.0 cm grid
of parallel 0.1 cm caliber bronze bars spaced 1.0 cm apart) was cov-
ered with a 7.0 cm wide, 5.0 cm high formica-covered platform.
The Illumination inside the roomwas 400–800 lux. Animals were
placed on the platform and the latency to step-down, placing their
four paws on the grid, was recorded. In the training session, imme-
diately after stepping down, a 0.7 or 0.5 mA, 3.0 s scrambled foot-
shock was delivered. In the test session, no foot-shock was given,
and a ceiling of 180 s was imposed on the step-down latency.2.5. Contextual fear conditioning (CFC)
The conditioning chamber consisted of an illuminated Plexiglas
box (25.0  25.0 cm grid of parallel 0.1-cm caliber stainless steel
bars spaced 1.0 cm apart). The Illumination inside the room was
400–800 lux. In the conditioning session (training), rats were
placed in the chamber for 3 min for habituation, and then received
two 2-s foot-shocks, either of 0.3 or 0.7 mA, separated by a 30-s
interval. Before returning to their home cages, animals were
kept in the conditioning environment for an additional minute.
Twenty-four hours later, all animals were tested during 5 min in
the same context.
2.6. Elevated plus maze
The elevated plus maze (EPM) test was conducted using a stan-
dard plus maze apparatus kept 80 cm above the ﬂoor, consisting of
four arms arranged in the shape of a plus sign (arms measured
50  10 cm). The four arms were joined at the center by a 10 cm
square platform. Two of the arms, opposite to each other, were sur-
rounded by a 1 cm high Plexiglas ledge (open arms), and two other
arms (closed arms) were enclosed by a 40-cm-high wall. The Illu-
mination inside the room was 50 lux. The animal was placed in
the center of the plus maze, facing one of the open arms, and re-
mained in the apparatus for 5 min. The number of entries and
the time spent in the open arm were analyzed.
2.7. Statistical analysis
Non-parametric statistics were necessary to analyze the step-
down latencies of IA task since these data were not normally dis-
tributed (P < 0.05, Kolmogorov–Smirnov test with Lilliefors’ correc-
tion). Independent groups were analyzed by Kruskal–Wallis test.
Wilcoxon signed ranks test were used to compare training vs. test.
In CFC, data was analyzed by One-way ANOVA, followed by Tukey
all-pairwise multiple comparison post-hoc test or independent t
test. Statistical analysis was limited to the 248 out of 263 animals
with correct cannulae placements (see Fig. 7). Statistical signiﬁ-
cance was accepted if P < 0.05.
2.8. Ethical aspects
All experimental procedures in living animals were performed
in strict accordance to the recommendations of the Brazilian Soci-
ety for Neurosciences (SBNeC) and Brazilian Law on the use of ani-
mals (Federal Law Nr. 11.794/2008).3. Results
3.1. Effect of TRPV1 agonist and antagonist in the inhibitory avoidance
task
In the ﬁrst sets of experiments, we investigated the role of the
vanilloid system in memory consolidation using the inhibitory
avoidance task. Rats received a bilateral intra-hippocampal infu-
sion of 0.1, 1 or 10 lM of the TRPV1 agonist capsaicin, immediately
after the training session, in which 0.5 mA foot-shock was applied.
There was no difference on step-down latencies among the groups,
neither in the training (P = 0.791) nor in the test sessions
(P = 0.392, Kruskal–Wallis ANOVA test; N = 10–12 per group). In
every group, training and test session latencies were signiﬁcantly
different, indicating that they have learned the task (P < 0.05, Wil-
coxon signed ranks test), as shown in Fig. 1.
Fig. 1. Effect of intrahippocampal infusion of capsaicin in step-down inhibitory
avoidance task (0.5 mA) upon memory consolidation. Kruskal–Wallis test shows no
signiﬁcant differences among training or test session latencies. Bars represent
interquartile ranges of step-down latencies, with the median as a thick line; ﬁne
horizontal lines represent minimum and maximum values. (a) Signiﬁcant differ-
ences between training and test session latencies (P < 0.05, Wilcoxon test, Ns = 11,
10, 12, 11).
Fig. 3. Effect of intrahippocampal infusion of capsazepine in the step-down
inhibitory avoidance task (0.7 mA) upon memory consolidation. Kruskal–Wallis
test shows no signiﬁcant differences among training or test session latencies. Bars
represent interquartile ranges of step-down latencies, with the median as a thick
line; ﬁne horizontal lines represent minimum and maximum values. (a) Signiﬁcant
differences between training and test session latencies (P < 0.05, Wilcoxon test,
Ns = 8, 9, 9, 10).
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hippocampal infusion of 2, 10 or 20 lM of the TRPV1 antagonist
capsazepine, is shown in Fig. 2. Step-down latencies were not dif-
ferent among the groups, neither in the training (P = 0.586) nor in
the test sessions (P = 0.277, Kruskal–Wallis ANOVA test; N = 10–12
per group). In every group, training and test session latencies were
signiﬁcantly different (P < 0.05, Wilcoxon signed ranks test) i.e., all
groups have learned the task. These results suggest that the TRPV1
receptors may not be required to modulate memory consolidation
of this task.
In the following experiment, we performed the same protocol,
but given a higher foot-shock in the training (0.7 mA). The perfor-
mance of rats receiving post-training bilateral intra-hippocampal
infusion of 2, 10 or 20 lM of the TRPV1 antagonist capsazepine,
is shown in Fig. 3. Step-down latencies were not different among
the groups, neither in the training (P = 0.450) nor in the test ses-
sions (P = 0.860, Kruskal–Wallis ANOVA test; N = 8–10 per group).
In the 10 lM group, but not in the other groups, there was no dif-
ference between the training and test session latencies (P > 0.05,
Wilcoxon signed ranks test). These results suggest that the TRPV1
receptors may be required to modulate memory consolidation of
this task under a high foot-shock training (0.7 mA), but not in a
lower one (0.5 mA).Fig. 2. Effect of intrahippocampal infusion of capsazepine in the step-down
inhibitory avoidance task (0.5 mA) upon memory consolidation. Kruskal–Wallis
test shows no signiﬁcant differences among training or test session latencies. Bars
represent interquartile ranges of step-down latencies, with the median as a thick
line; ﬁne horizontal lines represent minimum and maximum values. (a) Signiﬁcant
differences between training and test session latencies (P < 0.05, Wilcoxon test,
Ns = 12, 10, 11, 11).3.2. Effect of TRPV1 agonist and antagonist in the contextual fear
conditioning task
In the next experiment, we investigated whether using a more
aversive task would recruit the vanilloid system in order to modu-
late memory consolidation, as suggested by Marsch et al., 2007.
Thus, we have chosen the contextual fear conditioning task, in
which 0.7 mA foot-shock was applied.
Fig. 4 shows the freezing behavior exhibited during the test ses-
sion by animals that received a bilateral intra-hippocampal infusion
of 0.1, 1 or 10 lM of capsaicin after the CFC training. There was no
signiﬁcant difference among the groups (F(3,38) = 0.460, P = 0.712,
One-way ANOVA test; N = 9–13 per group).
Fig. 5 displays the freezing behavior performed during the test
session by animals that received a bilateral intra-hippocampal
infusion of 2, 10 or 20 lM of the TRPV1 antagonist capsazepine
after CFC training. There was a signiﬁcant difference among the
groups (F(3,35) = 3.233, P = 0.034, One-way ANOVA test). Tukey
post-hoc test revealed a signiﬁcant effect of 10 lM of capsazepine
that was able to impair memory compared with the control group
(P < 0.05).
We then asked whether the endovanilloid system was required
for memory consolidation in the case of a mild foot-shock (0.3 mA)
protocol in the same task. Fig. 6 shows the freezing behavior per-
formed during the test by animals that received bilateral intrahip-
pocampal infusion of the previously effective dose of capsazepineFig. 4. Effect of bilateral intrahippocampal infusion of capsaicin in the contextual
fear conditioning task (0.7 mA) upon memory consolidation. There were no
signiﬁcant differences among the groups in the freezing time spent in the test
session performed 24 h after conditioning (P > 0.05 One-way ANOVA, Ns = 9, 11, 13,
9). Data expressed as mean + SEM.
Fig. 5. Effect of bilateral intrahippocampal infusion of capsazepine in the contex-
tual fear conditioning task (0.7 mA) upon memory consolidation. TRPV1 blockade
by the antagonist impaired memory consolidation in this condition. Data expressed
as mean + SEM. (a) Post-hoc test after One-way ANOVA compared with the control
group, P < 0.05 (Ns = 11, 9, 9, 10).
Fig. 6. Effect of bilateral intrahippocampal infusion of capsazepine in the contex-
tual fear conditioning task (0.3 mA) upon memory consolidation. One-way ANOVA
test revealed no signiﬁcant differences between groups (P > 0.05, Ns = 9, 8, 8, 6).
Data expressed as mean + SEM.
Fig. 7. Typical acceptable needle placement, aimed at the CA1 region (according to
Paxinos and Watson (2007)) of the rat dorsal hippocampus (formol thionine
technique).
Table 1
Effect of intrahippocampal capsazepine infusion on the EPM.
Treatment N Mean SEM
Open arm entries Vehicle 8 2.8750 .78916
Cpz10 7 1.7143 .83707
Closed arm entries Vehicle 8 4.875 .83318
Cpz10 7 5.2857 .80812
[%] Tine spent on open arms Vehicle 8 10.7500 3.30329
Cpz10 7 8.4286 4.36237
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was no difference among the groups (F(3,27) = 0.143, P = 0.933;
N = 6–9 per group). Hence, these results suggest that the endova-
nilloid is recruited in order to modulate memory consolidation
through the hippocampal TRPV1 activation only when a strong
training is presented.
In order to exclude for any possible non-cognitive effect of the
effective dose of capsazepine, we tested some animals on theelevated plus maze task. Student t test revealed that there was
no difference of intra-hippocampal infusion of capsazepine neither
in the time spent in the open arms (t(13) = 0.431, P = 0.674) nor in
the number of entries in the open or closed arms (P > 0.05) com-
pared with the control group, as given in Table 1.
4. Discussion
The present study examined the role of the hippocampal endo-
vanilloid system upon memory consolidation in contextual fear
conditioning and step-down inhibitory avoidance. The main result
found here is that TRPV1 antagonist capsazepine was able to im-
pair memory consolidation only in the strong shock condition
(Figs. 3 and 5). In contrast, such effect was absent under a weak
conditioning protocol. These results suggest that endovanilloids
are required to modulate hippocampal memory consolidation only
when a strong emotional experience is present. Moreover, TRPV1
agonist capsaicin does not show any effect neither in fear condi-
tioning nor in step-down inhibitory avoidance task (Figs. 1 and 4).
We have chosen the dorsal region of the hippocampus because
it is involved with cognitive functions, such as IA and CFC memory
tasks (de Oliveira Alvares, Genro, Diehl, & Quillfeldt, 2008; de Oli-
veira Alvares et al., 2010). The ventral region is known to be related
to emotion and affect, not within our objectives. For a wider review
upon the functional distinction between dorsal and ventral hippo-
campus, see Fanselow & Dong, 2010.
Recent studies have described that endocannabinoid system is
recruited in the hippocampus in order to modulate memory under
a strong fear training protocol, but not under aweak one (deOliveira
Alvares et al., 2010) or less aversive tasks (de Oliveira Alvares et al.,
2006;Hölter et al., 2005;Niyuhire et al., 2007), suggesting that a cer-
tain level of aversiveness or emotional status is necessary to exert its
effect on memory (de Oliveira Alvares et al., 2010). Furthermore,
there are results reporting that anandamide release is increased in
response to stress (Hohmann et al., 2005), glucocorticoids (Di,
Malcher-Lopes, Halmos, & Tasker, 2003; Di, Malcher-Lopes, March-
eselli, Bazan, & Tasker, 2005) or emotional memories (Kamprath
et al., 2006;Marsicano et al., 2002). Some results from cannabinoids
research might be partially transposed to vanilloid studies since
anandamide is an endogenous ligand to both CB1 and TRPV1 recep-
tors. In fact, our current data corroborate these cannabinoid reports,
demonstrating an amnesic effect of capsazepine uponmemory con-
solidation, suggesting a modulatory inﬂuence by endovanilloids
such as anandamide upon TRPV1 receptors in a markedly stress-
ful/aversive learning.
TRPV1 receptor-deﬁcient mice have shown memory impair-
ment of contextual fear conditioning and LTP induction in hippo-
campus slices when compared with the wild-type littermate
(Marsch et al., 2007). In accordance with the present results, the ef-
fect of TRPV1 ablation was evident only after a strong conditioning
procedure (Marsch et al., 2007). Li and colleagues have reported
that TRPV1 agonist capsaicin has no effect per se in memory retrie-
val, but prevented the acute stress effect on spatial memory retrie-
val (Li et al., 2008).
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learning, where a signiﬁcant stressful experience such as a strong
foot-shock occur, endovanilloids may be acting upon TRPV1 recep-
tors in order to modulate positively memory consolidation.
Interestingly, at least in hippocampus, endovanilloids and endo-
cannabinoids seems to play a complementary role in memory con-
solidation, since CB1 blockade in CA1 area impair memory
consolidation (de Oliveira Alvares et al., 2005, 2006), and low con-
centration of anandamide in dorsal hippocampus improves mem-
ory (de Oliveira Alvares et al., 2008).
In addition, endocannabinoids/endovanilloids can enhance LTP
induction either through CB1 (Carlson, Wang, & Alger, 2002) or
TRPV1 (Li et al., 2008) activation in hippocampus. Despite the fact
that CB1 and TRPV1 have opposite transductional mechanisms
(inhibitory and excitatory, respectively), they are expressed at dif-
ferent synaptic sites – CB1 are located pre-synaptically both in
gabaergic and glutamatergic neurons, but are much more concen-
trated in the GABA synapse (Kawamura et al., 2006) – whereas
TRPV1 are found in the postsynaptic dendritic spines and cell so-
mata (Cristino et al., 2006; Tóth et al., 2005). This distribution
may explain the similar electrophysiological and behavioral results
both CB1 and TRPV1 activation seem to promote.
Therefore, based on the fact that (a) anandamide can act both as
endogenous cannabinoid and vanilloid, that (b) anandamide en-
hances memory consolidation, and that (c) CB1 or TRPV1 antago-
nists cause memory impairment only in a markedly aversive
learning situation, we suggest that the endocannabinoid and the
endovanilloid systems play a complementary role, at least in
memory consolidation processes taking place in the in dorsal
hippocampus.
In the inhibitory avoidance, we found a moderate effect on
memory consolidation using 0.7 mA foot-shock. The capsazepine
10 lM treated group did not learn the task (i.e., no difference be-
tween training and test latencies). However, no difference was
found when compared with the control group. Although both tasks
used in the present study involve aversive compounds, there are
some differences between them. In the IA, animals can avoid the
foot-shock, maintaining themselves on the platform. On the other
hand, in fear conditioning task, animals expect to receive the aver-
sive stimuli anytime. This difference becomes clear evaluating
their behavior. In the ﬁrst case, animals move and perform risk-
assessment, whereas in fear conditioning, they express fear re-
sponse through freezing around 70% of the whole time. Therefore,
it is reasonable to consider that contextual fear conditioning is
more aversive than the inhibitory avoidance task. In addition, in
the contextual fear conditioning, animals received more foot-
shocks than inhibitory avoidance paradigm in the protocol used
in this work. It also might explain the stronger effect found in
the contextual fear conditioning compared with the partial effect
shown in the IA task.
Due to their central and peripheric expression, TRPV1 receptors
can interfere on non-mnemonic aspects, such as mobility (de Lago,
de Miguel, Lastres-Becker, Ramos, & Fernández-Ruiz, 2004), anxi-
ety (Rubino et al., 2008) or pain perception (Cortright & Szallasi,
2009). Since these effects could overshadow the acquisition and/
or expression of memory, we have performed an additional behav-
ioral measurement in order to exclude the possibility of an anxiety
effect. Capsazepine infused into the dorsal hippocampus did not
cause any effect in the elevated plus maze compared to controls.
Thus, the effects presented here seem to be purely mnemonic.
In summary, our experiments suggest that the endovanilloid
system plays an important role upon memory consolidation acting
through the activation of TRPV1 receptors in the dorsal hippocam-
pus. However, it happens only when a certain level of aversiveness
is present, which seems to be a boundary condition for its recruit-
ment. The convergence of these results and others here citedsuggest that a synergic interaction is taking place between the
CB1 and the TRPV1 receptor in the dorsal hippocampus in order
to modulate memory consolidation.Acknowledgments
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